Self-assembled 20-nm 64Cu-micelles enhance accumulation in rat glioblastoma

Journal of Controlled Release

Volumn 220, Issue , 2015, Pages 51-60

  Seo, Jai Woong ^a   Ang, JooChuan ^b   Mahakian, Lisa M ^a   Tam, Sarah ^a   Fite, Brett ^a   Ingham, Elizabeth S ^a   Beyer, Janine ^c   Forsayeth, John ^c   Bankiewicz, Krystof S ^c   Xu, Ting ^b   Ferrara, Katherine W ^a  

^a University of California Davis   (United States)

^b University of California Berkeley   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BBB; Blood brain barrier; Drug delivery; Glioblastoma; Liposome; Micelles; Nanoparticle; PET; PET MR; Positron emission tomography

Indexed keywords

BIOLOGICAL MATERIALS; BLOOD; DRUG DELIVERY; LIPOSOMES; MAGNETIC RESONANCE; MAMMALS; MICELLES; NANOPARTICLES; POLYETHYLENE TEREPHTHALATES; POSITRONS; TUMORS;

BBB; BLOOD-BRAIN BARRIER; CIRCULATION HALF-LIFES; COILED-COIL PROTEINS; GLIOBLASTOMA MULTIFORME; GLIOBLASTOMAS; INTRAVENOUS INJECTIONS; POSITRON EMISSION TOMOGRAPHY (PET);

POSITRON EMISSION TOMOGRAPHY;

COPPER 64; LIPOSOME; NANOCARRIER; COPPER; MICELLE; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VOLUME; GLIOBLASTOMA; MALE; MICELLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN TERTIARY STRUCTURE; RAT; X RAY CRYSTALLOGRAPHY; AMINO ACID SEQUENCE; ANIMAL; AUTORADIOGRAPHY; BRAIN TUMOR; CHEMISTRY; DIAGNOSTIC IMAGING; HUMAN; MOLECULAR GENETICS; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANIMALS; AUTORADIOGRAPHY; BLOOD VOLUME; BRAIN NEOPLASMS; COPPER RADIOISOTOPES; GLIOBLASTOMA; HUMANS; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MALE; MICELLES; MOLECULAR SEQUENCE DATA; NANOPARTICLES; POSITRON-EMISSION TOMOGRAPHY; RATS; TISSUE DISTRIBUTION;

EID: 84944719510     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.09.057     Document Type: Article

References (59)

1. D.N. Louis, H. Ohgaki, O.D. Wiestler, and W.K. Cavanee WHO Classification of Tumours of the Central Nervous System 4th ed. 2007 IARC Press Lyon, France
2. M. Preusser, S. de Ribaupierre, A. Wohrer, S.C. Erridge, M. Hegi, M. Weller, and R. Stupp Current concepts and management of glioblastoma Ann. Neurol. 70 1 2011 9 21
3. P.Y. Wen, and S. Kesari Malignant gliomas in adults N. Engl. J. Med. 359 5 2008 492 507
4. F. Zustovich, G. Lombardi, A. Della Puppa, A. Rotilio, R. Scienza, and D. Pastorelli A phase II study of cisplatin and temozolomide in heavily pre-treated patients with temozolomide-refractory high-grade malignant glioma Anticancer Res. 29 10 2009 4275 4279
5. A.A. Brandes, U. Basso, M. Reni, F. Vastola, A. Tosoni, G. Cavallo, L. Scopece, A.J. Ferreri, M.G. Panucci, S. Monfardini, and et al. First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the gruppo italiano cooperativo di neuro-oncologia J. Clin. Oncol. 22 9 2004 1598 1604
6. G.B. Zhang, S.Y. Huang, and Z.C. Wang A meta-analysis of bevacizumab alone and in combination with irinotecan in the treatment of patients with recurrent glioblastoma multiforme J. Clin. Neurosci. 19 12 2012 1636 1640
7. J.J. Vredenburgh, A. Desjardins, D.A. Reardon, and H.S. Friedman Experience with irinotecan for the treatment of malignant glioma Neuro-Oncology 11 1 2009 80 91
8. H.S. Friedman, M.D. Prados, P.Y. Wen, T. Mikkelsen, D. Schiff, L.E. Abrey, W.K.A. Yung, N. Paleologos, M.K. Nicholas, R. Jensen, and et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma J. Clin. Oncol. 27 28 2009 4733 4740
9. G.M. Marx, N. Pavlakis, S. McCowatt, F.M. Boyle, J.A. Levi, D.R. Bell, R. Cook, M. Biggs, N. Little, and H.R. Wheeler Phase II study of thalidomide in the treatment of recurrent glioblastoma multiforme J. Neuro-Oncol. 54 1 2001 31 38
10. V.K. Puduvalli, P. Giglio, M.D. Groves, K.R. Hess, M.R. Gilbert, S. Mahankali, E.F. Jackson, V.A. Levin, C.A. Conrad, S.H. Hsu, and et al. Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme Neuro-Oncology 10 2 2008 216 222
11. M.R. Gilbert, J.J. Dignam, T.S. Armstrong, J.S. Wefel, D.T. Blumenthal, M.A. Vogelbaum, H. Colman, A. Chakravarti, S. Pugh, M. Won, and et al. A randomized trial of bevacizumab for newly diagnosed glioblastoma N. Engl. J. Med. 370 8 2014 699 708
12. O.L. Chinot, W. Wick, W. Mason, R. Henriksson, F. Saran, R. Nishikawa, A.F. Carpentier, K. Hoang-Xuan, P. Kavan, D. Cernea, and et al. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma N. Engl. J. Med. 370 8 2014 709 722
13. R. Stupp, M.E. Hegi, W.P. Mason, M.J. van den Bent, M.J.B. Taphoorn, R.C. Janzer, S.K. Ludwin, A. Allgeier, B. Fisher, K. Belanger, and et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol. 10 5 2009 459 466
14. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, M.J.B. Taphoorn, K. Belanger, A.A. Brandes, C. Marosi, U. Bogdahn, and et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N. Engl. J. Med. 352 10 2005 987 996
15. N.J. Abbott, L. Ronnback, and E. Hansson Astrocyte-endothelial interactions at the blood-brain barrier Nat. Rev. Neurosci. 7 1 2006 41 53
16. R.K. Oberoi, K.E. Parrish, T.T. Sio, R.K. Mittapalli, W.F. Elmquist, and J.N. Sarkaria Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma Neuro-Oncology 2015
17. S. Bhaskar, F. Tian, T. Stoeger, W. Kreyling, J.M. de la Fuente, V. Grazu, P. Borm, G. Estrada, V. Ntziachristos, and D. Razansky Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part Fibre Toxicol. 7 2010
18. I. Wilhelm, C. Fazakas, and I.A. Krizbai In vitro models of the blood-brain barrier Acta Neurobiol. Exp. 71 1 2011 113 128
19. H. Yang Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis Pharm. Res. 27 9 2010 1759 1771
20. X.Y. Xu, X.F. Zhang, X.H. Wang, Y.X. Li, and X.B. Jing Comparative study of paclitaxel physically encapsulated in and chemically conjugated with PEG-PLA Polym. Adv. Technol. 20 11 2009 843 848
21. A. Zensi, D. Begley, C. Pontikis, C. Legros, L. Mihoreanu, C. Buechel, and J. Kreuter Human serum albumin nanoparticles modified with apolipoprotein a-I cross the blood-brain barrier and enter the rodent brain J. Drug Target. 18 10 2010 842 848
22. A. Zensi, D. Begley, C. Pontikis, C. Legros, L. Mihoreanu, S. Wagner, C. Buechel, H. von Briesen, and J. Kreuter Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones J. Control. Release 137 1 2009 78 86
23. I. Miladi, G. Le Duc, D. Kryza, A. Berniard, P. Mowat, S. Roux, J. Taleb, P. Bonazza, P. Perriat, F. Lux, and et al. Biodistribution of ultra small gadolinium-based nanoparticles as theranostic agent: application to brain tumors J. Biomater. Appl. 28 3 2013 385 394
24. N.T. Huynh, M. Morille, J. Bejaud, P. Legras, A. Vessieres, G. Jaouen, J.P. Benoit, and C. Passirani Treatment of 9 L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect Pharm. Res. 28 12 2011 3189 3198
25. S.C.J. Steiniger, J. Kreuter, A.S. Khalansky, I.N. Skidan, A.I. Bobruskin, Z.S. Smirnova, S.E. Severin, R. Uhl, M. Kock, K.D. Geiger, and et al. Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles Int. J. Cancer 109 5 2004 759 767
26. Y. Yamashita, R. Saito, M.T. Krauze, T. Kawaguchi, C. Noble, D.C. Drummond, D.B. Kirpotin, J.W. Park, M.S. Berger, and K.S. Bankiewicz Convection-enhanced delivery of liposomal doxorubicin in intracranial brain tumor xenografts Target. Oncol. 1 2 2006 79 85
27. I. Brigger, J. Morizet, G. Aubert, H. Chacun, M.J. Terrier-Lacombe, P. Couvreur, and G. Vassal Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting J. Pharmacol. Exp. Ther. 303 3 2002 928 936
28. H. Cabral, Y. Matsumoto, K. Mizuno, Q. Chen, M. Murakami, M. Kimura, Y. Terada, M.R. Kano, K. Miyazono, M. Uesaka, and et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size Nat. Nanotechnol. 6 12 2011 815 823
29. M. Longmire, P.L. Choyke, and H. Kobayashi Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats Nanomedicine 3 5 2008 703 717
30. M. Horowitz, R. Blasberg, P. Molnar, J. Strong, P. Kornblith, R. Pleasants, and J. Fenstermacher Regional [misonidazole-C-14 distribution in experimental Rt-9-brain tumors Cancer Res. 43 8 1983 3800 3807
31. V.A. Levin, M. Freemandove, and H.D. Landahl Permeability characteristics of brain adjacent to tumors in rats Arch. Neurol. 32 12 1975 785 791
32. R.K. Oberoi, R.K. Mittapalli, and W.F. Elmquist Pharmacokinetic assessment of efflux transport in sunitinib distribution to the brain J. Pharmacol. Exp. Ther. 347 3 2013 755 764
33. S.K. Hobbs, W.L. Monsky, F. Yuan, W.G. Roberts, L. Griffith, V.P. Torchilin, and R.K. Jain Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment Proc. Natl. Acad. Sci. U. S. A. 95 8 1998 4607 4612
34. A.I. Minchinton, and I.F. Tannock Drug penetration in solid tumours Nat. Rev. Cancer 6 8 2006 583 592
35. Z. Popovic, W.H. Liu, V.P. Chauhan, J. Lee, C. Wong, A.B. Greytak, N. Insin, D.G. Nocera, D. Fukumura, R.K. Jain, and et al. A nanoparticle size series for in vivo fluorescence imaging Angew. Chem. Int. Ed. 49 46 2010 8649 8652
36. M.E. Fox, F.C. Szoka, and J.M.J. Frechet Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture Acc. Chem. Res. 42 8 2009 1141 1151
37. N. Nasongkla, B. Chen, N. Macaraeg, M.E. Fox, J.M.J. Frechet, and F.C. Szoka Dependence of pharmacokinetics and biodistribution on polymer architecture: effect of cyclic versus linear polymers J. Am. Chem. Soc. 131 11 2009 3842
38. H.L. Kim, S.B. Lee, H.J. Jeong, and D.W. Kim Enhanced tumor targetability of PEGylated mesoporous silica nanoparticles on in vivo optical imaging according to their size RSC Adv. 4 59 2014 31318 31322
39. 64Cu positron emission tomography (PET) imaging Bioconjug. Chem. 19 12 2008 2577 2584
40. H. Dong, N. Dube, J.Y. Shu, J.W. Seo, L.M. Mahakian, K.W. Ferrara, and T. Xu Long-circulating 15 nm micelles based on amphiphilic 3-helix peptide-PEG conjugates ACS Nano 6 6 2012 5320 5329
41. H. Dong, J.Y. Shu, N. Dube, Y. Ma, M.V. Tirrell, K.H. Downing, and T. Xu 3-Helix micelles stabilized by polymer springs J. Am. Chem. Soc. 134 28 2012 11807 11814
42. N. Dube, J.Y. Shu, H. Dong, J.W. Seo, E. Ingham, A. Kheirolomoom, P.-Y. Chen, J. Forsayeth, K. Bankiewicz, K.W. Ferrara, and et al. Evaluation of doxorubicin-loaded 3-helix micelles as nanocarriers Biomacromolecules 14 10 2013 3697 3705
43. N. Dube, J.W. Seo, H. Dong, J.Y. Shu, R. Lund, L.M. Mahakian, K.W. Ferrara, and T. Xu Effect of alkyl length of peptide-polymer amphiphile on cargo encapsulation stability and pharmacokinetics of 3-helix micelles Biomacromolecules 15 8 2014 2963 2970
44. H. Dong, R. Lund, and T. Xu Micelle stabilization via entropic repulsion: balance of force directionality and geometric packing of subunit Biomacromolecules 16 3 2015 743 747
45. N.L. Ogihara, M.S. Weiss, D. Eisenberg, and W.F. Degrado The crystal structure of the designed trimeric coiled coil coil-VaLd: implications for engineering crystals and supramolecular assemblies Protein Sci. 6 1 1997 80 88
46. J.Y. Shu, C. Tan, W.F. DeGrado, and T. Xu New design of helix bundle peptide-polymer conjugates Biomacromolecules 9 8 2008 2111 2117
47. H.B. Lee, and M.D. Blaufox Blood-volume in the rat J. Nucl. Med. 26 1 1985 72 76
48. H.J. Aronen, I.E. Gazit, D.N. Louis, B.R. Buchbinder, F.S. Pardo, R.M. Weisskoff, G.R. Harsh, G.R. Cosgrove, E.F. Halpern, F.H. Hochberg, and et al. Cerebral blood-volume maps of gliomas - comparison with tumor grade and histologic-findings Radiology 191 1 1994 41 51
49. C.F. vanDijke, R.C. Brasch, T.P.L. Roberts, N. Weidner, A. Mathur, D.M. Shames, J.S. Mann, F. Demsar, P. Lang, and H.C. Schwickert Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density Radiology 198 3 1996 813 818
50. J. Dennie, J.B. Mandeville, J.L. Boxerman, S.D. Packard, B.R. Rosen, and R.M. Weisskoff NMR imaging of changes in vascular morphology due to tumor angiogenesis Magn. Reson. Med. 40 6 1998 793 799
51. C. Engvall, E. Ryding, R. Wirestam, S. Holtas, K. Ljunggren, T. Ohlsson, and P. Reinstrup Human cerebral blood volume (CBV) measured by dynamic susceptibility contrast MRI and Tc-99 m-RBC SPECT J. Neurosurg. Anesthesiol. 20 1 2008 41 44
52. M.I. Koukourakis, S. Koukouraki, I. Fezoulidis, N. Kelekis, G. Kyrias, S. Archimandritis, and N. Karkavitsas High intratumoural accumulation of stealth (R) liposomal doxorubicin (caelyx (R)) in glioblastomas and in metastatic brain tumours Br. J. Cancer 83 10 2000 1281 1286
53. D.R. Senger, L.F. Brown, K.P. Claffey, and H.F. Dvorak Vascular-permeability factor, tumor angiogenesis and stroma generation Invasion Metastasis 14 1-6 1994 385 394
54. J.W. Seo, L.M. Mahakian, A. Kheirolomoom, H. Zhang, C.F. Meares, R. Ferdani, C.J. Anderson, and K.W. Ferrara Liposomal Cu-64 labeling method using bifunctional chelators: poly(ethylene glycol) spacer and chelator effects Bioconjug. Chem. 21 7 2010 1206 1215
55. E.T.M. Dams, P. Laverman, W.J.G. Oyen, G. Storm, G.L. Scherphof, J.W.M. Van der Meer, F.H.M. Corstens, and O.C. Boerman Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes J. Pharmacol. Exp. Ther. 292 3 2000 1071 1079
56. C. Ricard, F. Stanchi, T. Rodriguez, M.C. Amoureux, G. Rougon, and F. Debarbieux Dynamic quantitative intravital imaging of glioblastoma progression reveals a lack of correlation between tumor growth and blood vessel density PLoS One 8 9 2013 15
57. B.R. Deane, and P.L. Lantos The vasculature of experimental brain-tumors.1. A sequential light and electron-microscope study of angiogenesis J. Neurol. Sci. 49 1 1981 55 66
58. N. Nghi, J. Montagnese, L.R. Rogers, A. Sher, and L. Wolansky Positron emission tomography-magnetic resonance imaging in the evaluation of brain tumors: current status and future prospects Semin. Roentgenol. 49 3 2014 275 289
59. B. Ertl-Wagner, M. Ingrisch, M. Niyazi, O. Schnell, N. Jansen, S. Forster, and C. la Fougere PET-MR in patients with glioblastoma multiforme Radiologe 53 8 2013 682 690